Stockscreener 앱 받기
0.1173
45.92%
-0.0996
시장 영업 전:
.11
-0.0073
-6.22%
전일 마감가:
$0.2169
열려 있는:
$0.12715
하루 거래량:
37.84M
Relative Volume:
2.83
시가총액:
$16.93M
수익:
-
순이익/손실:
$-119.76M
주가수익비율:
-0.0869
EPS:
-1.35
순현금흐름:
$-55.17M
1주 성능:
-45.84%
1개월 성능:
-87.11%
6개월 성능:
-67.86%
1년 성능:
-89.71%
1일 변동 폭
$0.11
$0.1293
1주일 범위
$0.11
$0.258
52주 변동 폭
$0.11
$1.50
Applied Therapeutics Inc Stock (APLT) Company Profile
명칭
Applied Therapeutics Inc
전화
212-220-9226
주소
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
APLT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
APLT
Applied Therapeutics Inc
|
0.1173 | 31.30M | 0 | -119.76M | -55.17M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-12-03 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-12-23 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-12-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-11-29 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-07-31 | 개시 | William Blair | Outperform |
| 2024-03-26 | 개시 | RBC Capital Mkts | Outperform |
| 2024-02-22 | 개시 | Leerink Partners | Outperform |
| 2022-01-04 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2021-08-27 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-06-25 | 재개 | Goldman | Neutral |
| 2020-10-08 | 개시 | Truist | Buy |
| 2020-04-22 | 개시 | Goldman | Buy |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2019-06-10 | 개시 | Citigroup | Buy |
| 2019-06-10 | 개시 | Cowen | Outperform |
| 2019-06-10 | 개시 | Robert W. Baird | Outperform |
모두보기
Applied Therapeutics Inc 주식(APLT)의 최신 뉴스
Halper Sadeh LLC Encourages ALEX, DXLG, APLT Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.
Applied Therapeutics stock rating downgraded to Neutral by Baird - Investing.com Nigeria
Cycle buying Applied Therapeutics to develop CNS drugs - BioWorld MedTech
S&P 500 Down 1%; Broadcom Earnings Top Views - Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Cycle Pharma to acquire Applied Therapeutics - The Pharma Letter
Cycle Group Holdings Limited entered into a definitive agreement to acquire Applied Therapeutics, Inc. for $13.4 million. - marketscreener.com
Dow Rises Over 100 Points; Lululemon Posts Upbeat Q3 Earnings - Benzinga
Applied Therapeutics (APLT) Stock News Today: Cycle Deal Details, CVR Upside, and Analyst Outlook (Dec. 12, 2025) - ts2.tech
RBC Cuts Price Target on Applied Therapeutics to $0.25 From $1, Keeps Sector Perform, Speculative Risk - marketscreener.com
APLT Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Applied Therapeutics, Inc. is Fair to Shareholders - The AI Journal
Applied Therapeutics Announces Merger with Cycle Group - TipRanks
Applied Therapeutics plunges after UK's Cycle Group to buy co - TradingView — Track All Markets
Why Lululemon Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Applied Therapeutics stock price target lowered by RBC on Cycle acquisition - Investing.com UK
Applied Therapeutics To Be Acquired By Privately Held Cycle Group - Nasdaq
Cycle Pharmaceuticals to Acquire Applied Therapeutics - citybiz
Cycle Pharmaceuticals acquiring Applied Therapeutics - MSN
Cycle Group to Acquire Applied Therapeutics (APLT) in Strategic Deal - GuruFocus
Cycle to buy Applied Therapeutics (Nasdaq: APLT) in cash, CVR deal closing in Q1 2026 - Stock Titan
Published on: 2025-12-05 04:31:49 - Newser
Is Applied Therapeutics Inc. stock a buy on dipsJuly 2025 Gainers & Weekly Sector Rotation Insights - Newser
Is Applied Therapeutics Inc. (2UV) stock prepared for digital transition2025 Short Interest & Verified Technical Signals - Newser
Can Applied Therapeutics Inc. (2UV) stock surprise markets with earningsPortfolio Growth Summary & High Accuracy Buy Signal Tips - Newser
How Applied Therapeutics Inc. (2UV) stock moves in volatile trading sessions2025 Trade Ideas & Real-Time Stock Movement Alerts - Newser
Can Applied Therapeutics Inc. (2UV) stock double in coming yearsWeekly Profit Recap & AI Optimized Trade Strategies - Newser
Applied Therapeutics stock rating downgraded by Leerink Partners on cash concerns - Investing.com Nigeria
APLT Downgraded by Leerink Partners: Key Analyst Update | APLT S - GuruFocus
Why Applied Therapeutics Inc. (2UV) stock fits value portfoliosTrade Performance Summary & Low Volatility Stock Suggestions - Newser
Why Applied Therapeutics Inc. (2UV) stock trades below fair value2025 Biggest Moves & Fast Moving Market Watchlists - Newser
What analysts say about Applied Therapeutics Inc stockHead and Shoulders Patterns & Minimal Investment Trading - earlytimes.in
Would You Still Hold Applied Therapeutics Stock If It Fell Another 30%? - Trefis
Applied Therapeutics (APLT) Upgraded to Buy: Here's Why - MSN
Applied Therapeutics Reports Third Quarter 2025 Financial Results - ADVFN
Finance Watch: Poxel Pulls Back From The Brink With Recovery Plan - Citeline News & Insights
Applied Therapeutics To Lay Off Nearly Half Its Staff, Board Explores M&A Options - MSN
Applied Therapeutics (APLT) Stock Price, Quote, News & History - Benzinga
Applied Therapeutics Investors Get 1st OK For $15M Deal - Law360
Why Applied Therapeutics Inc. stock could see breakout soonMarket Trend Review & Weekly Momentum Stock Picks - newser.com
Applied Therapeutics explores strategic alternatives amid workforce cuts By Investing.com - Investing.com Nigeria
Applied Therapeutics Announces Corporate Updates - Investing News Network
Applied Therapeutics, Inc. Initiates Strategic Alternatives Review - TradingView
Applied Therapeutics explores strategic alternatives amid workforce cuts - Investing.com
APLT Evaluates Strategic Options as Workforce Reductions Announced - GuruFocus
APLT Evaluates FDA Meeting Outcomes for Govorestat Development P - GuruFocus
What data driven models say about Applied Therapeutics Inc.’s future - newser.com
Applied Therapeutics (Nasdaq: APLT) to Explore Strategic Alternatives, Reduce Workforce 46% - Stock Titan
Applied Therapeutics Inc (APLT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Applied Therapeutics Inc 주식 (APLT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Funtleyder Leslie D. | See Remarks |
Mar 04 '25 |
Sale |
0.44 |
14,502 |
6,381 |
390,459 |
| Chinoporos Constantine | See Remarks |
Mar 04 '25 |
Sale |
0.44 |
447 |
197 |
271,436 |
| Funtleyder Leslie D. | See Remarks |
Feb 06 '25 |
Sale |
0.61 |
22,950 |
14,000 |
404,961 |
| Perfetti Riccardo | Chief Medical Officer |
Feb 06 '25 |
Sale |
0.61 |
86,078 |
52,508 |
900,775 |
| Chinoporos Constantine | See Remarks |
Feb 06 '25 |
Sale |
0.61 |
28,117 |
17,151 |
271,883 |
1.08%
0.91%
자본화:
|
볼륨(24시간):